Isofol Medical
Clinical-stage biotech developing a folate-based therapy to enhance cancer treatments.
ISOFOL | ST
Overview
Corporate Details
- ISIN(s):
- SE0009581051
- LEI:
- 549300MCXYAHG7VBHX75
- Country:
- Sweden
- Address:
- C/O Biotech Center, Arvid Wallgrens, 413 46 Göteborg
- Website:
- https://isofolmedical.com/
Description
Isofol Medical is a clinical-stage biotechnology company dedicated to improving treatments for severe forms of cancer. The company's primary focus is the development of its lead drug candidate, arfolitixorin. This next-generation, folate-based therapy is designed to enhance the efficacy of standard cancer treatments, such as chemotherapy. Arfolitixorin is the active metabolite of commonly used folate-based drugs, potentially offering a therapeutic benefit to a broader patient population by bypassing complex metabolic activation steps. The company's goal is to help more patients respond better to their treatment, thereby improving their prognosis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-12-28 19:30 |
Isofol presents additional results from laboratory tests with arfolitixorin sho…
|
English | 106.2 KB | ||
| 2023-12-13 13:15 |
Isofol’s board of directors announces its position on minority shareholder's pr…
|
English | 104.1 KB | ||
| 2023-12-13 13:15 |
Styrelsen i Isofol meddelar sin inställning till minoritetsaktieägares förslag …
|
Swedish | 63.2 KB | ||
| 2023-12-11 10:02 | English | 35.2 KB | |||
| 2023-12-08 10:20 | English | 35.4 KB | |||
| 2023-12-07 20:31 |
Isofol has received the first results from laboratory tests of arfolitixorin
|
English | 108.3 KB | ||
| 2023-12-07 20:31 |
Isofol har tagit del av de första resultaten från laboratorieförsök med arfolit…
|
Swedish | 68.3 KB | ||
| 2023-12-01 09:00 |
Isofol is liquidating a subsidiary
|
English | 57.5 KB | ||
| 2023-12-01 09:00 |
Isofol avvecklar dotterbolag
|
Swedish | 57.4 KB | ||
| 2023-11-27 10:14 | English | 35.2 KB | |||
| 2023-11-21 14:40 |
Kallelse till extra bolagsstämma i Isofol Medical AB (publ) den 4 januari 2024
|
Swedish | 164.3 KB | ||
| 2023-11-21 14:40 |
Notice convening the Extraordinary General Meeting in Isofol Medical AB (publ) …
|
English | 146.1 KB | ||
| 2023-11-10 08:00 | Swedish | 533.8 KB | |||
| 2023-11-10 08:00 | English | 533.8 KB | |||
| 2023-11-09 12:55 |
Isofol har erhållit begäran om att kalla till extra bolagsstämma
|
Swedish | 57.2 KB |
Automate Your Workflow. Get a real-time feed of all Isofol Medical filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Isofol Medical
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Isofol Medical via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-11 | Magnus Hurst | Other | Buy | 35,000 | 24,150.00 SEK |
| 2022-09-12 | AB Windar | Other | Buy | 500,000 | 305,000.00 SEK |
| 2021-12-09 | Tony Gustavsson | Other | Sell | 58,767 | 858.00 SEK |
| 2021-12-09 | Tony Gustavsson | Other | Sell | 58,767 | 152.79 SEK |
| 2021-06-14 | HealthCom GmbH | Other | Buy | 233,336 | 1,493,350.40 SEK |
| 2021-06-10 | Gustaf Albèrt | Other | Other | 15,153 | 96,979.20 SEK |
| 2020-11-23 | Tony Gustavsson | Other | Buy | 58,767 | 43,487.58 SEK |
| 2020-11-23 | Tony Gustavsson | Other | Buy | 58,767 | 29,971.17 SEK |
| 2020-11-16 | Sven Eriksson | Other | Sell | 58,767 | 43,487.58 SEK |
| 2020-11-16 | Sven Eriksson | Other | Sell | 58,767 | 29,971.17 SEK |
Peer Companies
